Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I V Dolzhikova

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Vestnik Rossiiskoi Akademii Meditsinskikh Nauk|January 4, 2018
[Energy Metabolism in the Placenta and the Role of Disturbances in the Development of Placental Insufficiency at an Exacerbation of Cytomegalovirus Infection]M T Lucenko, I A Andrievskaya, I V Dolzhikova
Voprosy Virusologii|March 8, 2021
[Ebola virus (<i>Filoviridae: Ebolavirus: Zaire ebolavirus</i>): fatal adaptation mutations]I V Dolzhikova, D N Shcherbinin, D Yu Logunov, et al.
Voprosy Virusologii|December 29, 2023
[Vaccines to prevent Ebola virus disease: current challenges and perspectives]A V Kovyrshina, T E Sizikova, V N Lebedev, et al.
Voprosy Virusologii|May 16, 2021
[Review of candidate vaccines for the prevention of Lassa fever]O D Popova, O V Zubkova, T A Ozharovskaia, et al.
Acta Naturae|November 7, 2017
Virus-Vectored Ebola VaccinesI V Dolzhikova, E A Tokarskaya, A S Dzharullaeva, et al.
Acta Naturae|April 27, 2019
Immunogenicity of Different Forms of Middle East Respiratory Syndrome S GlycoproteinT A Ozharovskaia, O V Zubkova, I V Dolzhikova, et al.
Acta Naturae|April 23, 2025
The Parameters of Long-Term Humoral Immunity Induced by a Single Injection of the Sputnik Light Vaccine Among Noninfected Volunteers and Those Infected with SARS-CoV-2F M Izhaeva, A I Tukhvatulin, A S Dzharullaeva, et al.
Acta Naturae|November 11, 2020
Preclinical Studies of Immunogenity, Protectivity, and Safety of the Combined Vector Vaccine for Prevention of the Middle East Respiratory SyndromeI V Dolzhikova, D M Grousova, O V Zubkova, et al.
Acta Naturae|January 18, 2024
In Vitro Antiviral Activity of a New Indol-3-carboxylic Acid Derivative Against SARS-CoV-2A N Narovlyansky, M V Filimonova, N G Tsyshkova, et al.
Human Vaccines & Immunotherapeutics|February 3, 2017
Safety and immunogenicity of GamEvac-Combi, a heterologous VSV- and Ad5-vectored Ebola vaccine: An open phase I/II trial in healthy adults in RussiaI V Dolzhikova, O V Zubkova, A I Tukhvatulin, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Vestnik Rossiiskoi Akademii Meditsinskikh Nauk|January 4, 2018
[Energy Metabolism in the Placenta and the Role of Disturbances in the Development of Placental Insufficiency at an Exacerbation of Cytomegalovirus Infection]M T Lucenko, I A Andrievskaya, I V Dolzhikova
Voprosy Virusologii|March 8, 2021
[Ebola virus (<i>Filoviridae: Ebolavirus: Zaire ebolavirus</i>): fatal adaptation mutations]I V Dolzhikova, D N Shcherbinin, D Yu Logunov, et al.
Voprosy Virusologii|December 29, 2023
[Vaccines to prevent Ebola virus disease: current challenges and perspectives]A V Kovyrshina, T E Sizikova, V N Lebedev, et al.
Voprosy Virusologii|May 16, 2021
[Review of candidate vaccines for the prevention of Lassa fever]O D Popova, O V Zubkova, T A Ozharovskaia, et al.
Acta Naturae|November 7, 2017
Virus-Vectored Ebola VaccinesI V Dolzhikova, E A Tokarskaya, A S Dzharullaeva, et al.
Acta Naturae|April 27, 2019
Immunogenicity of Different Forms of Middle East Respiratory Syndrome S GlycoproteinT A Ozharovskaia, O V Zubkova, I V Dolzhikova, et al.
Acta Naturae|April 23, 2025
The Parameters of Long-Term Humoral Immunity Induced by a Single Injection of the Sputnik Light Vaccine Among Noninfected Volunteers and Those Infected with SARS-CoV-2F M Izhaeva, A I Tukhvatulin, A S Dzharullaeva, et al.
Acta Naturae|November 11, 2020
Preclinical Studies of Immunogenity, Protectivity, and Safety of the Combined Vector Vaccine for Prevention of the Middle East Respiratory SyndromeI V Dolzhikova, D M Grousova, O V Zubkova, et al.
Acta Naturae|January 18, 2024
In Vitro Antiviral Activity of a New Indol-3-carboxylic Acid Derivative Against SARS-CoV-2A N Narovlyansky, M V Filimonova, N G Tsyshkova, et al.
Human Vaccines & Immunotherapeutics|February 3, 2017
Safety and immunogenicity of GamEvac-Combi, a heterologous VSV- and Ad5-vectored Ebola vaccine: An open phase I/II trial in healthy adults in RussiaI V Dolzhikova, O V Zubkova, A I Tukhvatulin, et al.
Pageof 1